A conference on metabolic imaging and spectroscopy
The Third Britton Chance International Symposium on Metabolic Imaging and Spectroscopy
This conference is bringing together doctors and scientists to share ideas about how our body's metabolism affects diseases like cancer, diabetes, and brain disorders, with the goal of finding better ways to help patients through new imaging techniques and teamwork.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-11000644 on NIH RePORTER |
What this research studies
This conference aims to gather clinicians and scientists from various fields to discuss and advance the understanding of metabolic processes relevant to diseases like cancer, diabetes, and neurological disorders. Participants will engage in sessions focused on the latest techniques in metabolic imaging and spectroscopy, fostering collaboration across disciplines. The event will emphasize the clinical applications of these technologies and their potential to improve patient care. By bringing together experts, the conference seeks to enhance the translation of research findings into practical medical solutions.
Who could benefit from this research
Good fit: Patients with conditions such as cancer, diabetes, or neurological disorders may benefit from the advancements discussed at this conference.
Not a fit: Patients not affected by metabolic diseases or those outside the scope of the discussed conditions may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this conference could lead to improved diagnostic and treatment strategies for patients with metabolic-related diseases.
How similar studies have performed: Previous conferences on similar topics have successfully fostered collaboration and innovation in metabolic imaging, indicating a positive track record.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Li, Lin Z — University of Pennsylvania
- Study coordinator: Li, Lin Z
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.